Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,734.00    12.00 (0.25%)
Bid:
4,732.00
Ask:
4,736.00
Spread: 4.00 (0.085%)
Market Cap: £17.88b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Director/PDMR Shareholding

8 Jul 2009 12:12

RNS Number : 3346V
Halma PLC
08 July 2009
 



HALMA p.l.c. DIRECTORS' AND PDMRsSHARE TRANSACTIONS

In accordance with 3.1.2R of the Disclosure Rules, notification is hereby given that the following Directors and senior executives (persons discharging managerial responsibility) have exercised share options and have received vested performance share awards, all on 7 July 2009.

After the transactions set out below, the beneficial holdings of Directors and PDMRs, including family interests, in the 10p ordinary shares of Halma have increased as follows:

Increase by

Beneficial holding

% of issued ordinary  share capital excluding treasury shares

Andrew J Williams

99,851

272,744

0.0727

Kevin J Thompson

8,401

168,683

0.0450

Neil Quinn

71,305

163,689

0.0436

Adam J Meyers

56,342

124,943

0.0333

John S Campbell

57,796

145,353

0.0387

Nigel J B Trodd

38,129

65,366

0.0174

Mark S Lavelle

11,622

23,922

0.0064

Allan Stamper

16,541

25,818

0.0069

Charles E Dubois

9,994

14,729

0.0039

Carol T Chesney

9,759

22,628

0.0060

EXERCISE OF SHARE OPTIONS

At a meeting of the Share Plans Committee of the Board of Halma held on 07 July 2009, additional ordinary shares in the Company were allotted under the provisions of the Company's 1996 Unapproved Executive Share Option Scheme to Directors and PDMRs of the Company, following the exercise of share options, at an exercise price of 120p per share, as set out below.

These options were awarded in August 1999 and would lapse if not exercised by their tenth anniversary.

In addition, primarily to finance the exercise of the share options and the associated tax liabilitiesDirectors and PDMRs sold shares as set out below on 7 July 2009 at 194.7183p per share.

No of shares awarded

No of shares sold

Andrew J Williams

14,400

11,113

Kevin J Thompson

36,800

28,399

Neil Quinn

40,500

40,500

Adam J Meyers

23,300

14,396

John S Campbell

29,400

20,991

Charles E Dubois

14,900

14,900

Carol T Chesney

16,900

16,900

VESTING OF PERFORMANCE SHARE AWARDS 

Notification is given relating to Performance Share Plan ('PSP') awards originally granted on 07 July 2006 and which vested on 7 July 2009 at 91.25% of the original award in accordance with the Rules of the PSP and the relevant performance criteria. Further to the vesting, shares were sold on 7 July 2009 primarily to finance the associated tax liability at 196.4592p per share. Details are as follows:

Vested 07.07.09 No of shares

No of shares sold

Andrew J Williams

224,685

128,121

Kevin J Thompson

150,860

150,860

Neil Quinn

120,856

49,551

Adam J Meyers

74,647

27,209

John S Campbell

77,714

28,327

Nigel J B Trodd

64,627

26,498

Mark S Lavelle

19,699

8,077

Allan Stamper

16,541

0

Charles E Dubois

14,167

4,173

Carol T Chesney

16,541

6,782

Following the issue of ordinary shares as a result of transactions exercised on 7 July 2009, the issued ordinary share capital of the Company, excluding treasury shares, is increased to 375,185,420 shares.

Contact for further information:

Carol T Chesney

Company Secretary, Halma p.l.c. Tel: +44 (0)1494 721111

A copy of this announcement, together with other information about Halma, may be viewed on its web site: www.halma.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFVLFBKDBFBBB
Date   Source Headline
28th May 20267:15 amRNSExecutive Board changes
13th Apr 20267:00 amRNSAcquisition
12th Mar 20267:00 amRNSTrading Update
13th Jan 20269:18 amRNSDirector/PDMR Shareholding
9th Jan 20261:26 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSAcquisition
5th Dec 20257:00 amRNSAcquisition
20th Nov 20257:00 amRNSHalf Year Results
1st Oct 20252:00 pmRNSDirector/PDMR Shareholding
26th Sep 202510:19 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAcquisition
24th Jul 20252:15 pmRNSResult of AGM
30th Jun 202511:30 amRNSDirector/PDMR Shareholding
25th Jun 20258:30 amRNSAGM - Revised Form of Proxy
24th Jun 20259:20 amRNSDirector/PDMR Shareholding
20th Jun 20255:15 pmRNSAnnual Financial Report
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSFull Year Results
16th May 20257:00 amRNSDirectorate Change
28th Mar 20251:10 pmRNSDirector/PDMR Shareholding
21st Mar 20252:00 pmRNSDirectorate Change
13th Mar 20257:00 amRNSTrading Update
28th Feb 20254:29 pmRNSDirector/PDMR Shareholding
14th Jan 20252:05 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSAppointment of Chief Financial Officer
28th Nov 202410:04 amRNSDirector/PDMR Shareholding
22nd Nov 20243:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20243:26 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSHalf Year Results
18th Nov 20247:00 amRNSAcquisition
6th Nov 20242:34 pmRNSDirector Declaration
2nd Oct 20249:20 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSTrading Update
24th Sep 20249:45 amRNSDirector/PDMR Shareholding
3rd Sep 20249:15 amRNSPDMR Shareholding
25th Jul 20241:51 pmRNSResult of AGM
24th Jul 20249:15 amRNSDirector/PDMR Shareholding
17th Jul 202412:46 pmRNSDirector Declaration
1st Jul 20249:51 amRNSDirector/PDMR Shareholding
27th Jun 20247:00 amRNSAcquisition
25th Jun 20243:00 pmRNSDirector/PDMR Shareholding
24th Jun 20245:26 pmRNSAnnual Financial Report
13th Jun 20247:00 amRNSFull Year Results
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.